Tenax Therapeutics TENX
NASDAQ TENX
$1.89 +0.05 (+2.72%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Current Debt (2011 - 2015)

Updated

Tenax Therapeutics' Current Debt came in at $172,025 for FY2015, up 21.7% from $141,320 in FY2014.

Analysis

Tenax Therapeutics (TENX) Current Debt (2011 - 2015) Analysis & Trends

Going back to FY2011, Tenax Therapeutics' Current Debt data covers 5 years.

  • Current Debt carries a four-year compound annual growth rate of -55.5% (FY2011 to FY2015).
  • The FY2015 figure represents the highest annual Current Debt since FY2012.
  • Per Business Quant, earlier years put Current Debt at $141,320 in FY2014 (+37.6%), $102,671 in FY2013 (-87.7%), $837,692 in FY2012 (-80.9%) and $4.39 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 37.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tenax Therapeutics 85.48 Mn 85.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -172,025.00
Jan 31, 2015 172,025.00
Jan 31, 2014 -4.75 Mn
Oct 31, 2013 -24,995.00
Jul 31, 2013 4.92 Mn
Jan 31, 2013 102,671.00
Jan 31, 2012 137,692.00
Jul 31, 2011 700,000.00
Apr 30, 2011 2.30 Mn
Jan 31, 2011 2.09 Mn
API Access

Tenax Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TENX&period=max&api_key=YOUR_API_KEY